Home > Balance Sheet > BAFNA PHARMACEUTICALS

BAFNA PHARMACEUTICALS
Contingent Liabilities

    Back to Balance Sheet
AD     Remove this Ad

BAFNA PHARMACEUTICALS Last 5 Year Contingent Liabilities History

[Standalone]

Mar2025Mar2024Mar2023Mar2022Mar2021
Contingent Liabilities ₹18 Cr₹18 Cr₹10 Cr₹6.17 Cr₹2.00 Cr

What is the latest Contingent Liabilities ratio of BAFNA PHARMACEUTICALS ?

The latest Contingent Liabilities ratio of BAFNA PHARMACEUTICALS is ₹18 Cr based on Mar2025 Standalone results.
Year Contingent Liabilities
Mar2025₹18 Cr
Mar2024₹18 Cr
Mar2023₹10 Cr
Mar2022₹6.17 Cr
Mar2021₹2.00 Cr

How is Contingent Liabilities of BAFNA PHARMACEUTICALS Trending?

Years Contingent Liabilities % Change
Mar2025 ₹18 Cr
-0.06
Mar2024 ₹18 Cr
67.43
Mar2023 ₹10 Cr
69.85
Mar2022 ₹6.17 Cr
208.45
Mar2021 ₹2.00 Cr -

Compare Contingent Liabilities of peers of BAFNA PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BAFNA PHARMACEUTICALS ₹263.1 Cr -6.4% 3.4% 43.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹406,603.0 Cr -5.6% -2.5% -1.7% Stock Analytics
DIVIS LABORATORIES ₹155,485.0 Cr -2.6% -8.7% 1.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹135,009.0 Cr -7.2% -8% 27.6% Stock Analytics
DR REDDYS LABORATORIES ₹101,628.0 Cr -6.5% -5.4% 3.9% Stock Analytics
CIPLA ₹96,400.8 Cr -4.1% -11.5% -19% Stock Analytics


BAFNA PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
BAFNA PHARMACEUTICALS

-6.4%

3.4%

43.9%

SENSEX

-1%

-10.9%

-6%


You may also like the below Video Courses